Based on the above studies, we can speculate that regulating the hypoxic microenvironment and its associated HIF-1α upstream and downstream gene expression, such as VEGF, RIG-I and JAK/STAT3/HIF signaling pathways, may effectively reduce vascular inflammation and mitochondrial calcification in DM patients. This evidence concerns the gene HIF1A and dermatomyositis.